Table 1 Patient’s characteristics - 3 Centers - (MitroFix© Device)
From: Mitral valve restoration using the No-React(R) MitroFix™: a novel concept
N valid | |||
|---|---|---|---|
Age at surgery (mean) | 51 | 67,58 | |
Range:52- | |||
Gender | 51 | ||
Males | 32 (62,7%) | ||
Females | 19 (37,3%) | ||
Preoperative clinical status | |||
NYHA class | 51 | ||
II | 6 (11,8%) | ||
II-III | 7 (13,7%) | ||
III | 24 (47,1%) | ||
III-IV | 6 (11,8%) | ||
IV | 8 (15,7%) | ||
Atrial fibrillation | 51 | 21 (41,2%) | |
Additional cardiac diseases | 51 | ||
None | 20 (39,2%) | ||
Cardiac artery disease | 18 (35,3%) | ||
Aortic valve disease | 4 (7,8%) | ||
Tricuspid valve disease | 13 (25,5%) | ||
Persistant foramen ovale | 3 (5,9%) | ||
Redo | 2 (3,9%) | ||
AAA | 1 (2,0%) | ||
Mitral regurgitation (preop) | |||
III | 17 (33,3%) | ||
III-IV | 10 (19,6%) | ||
IV | 24 (47,1%) | ||